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ABSTRACT
PATHOGENIC ROLE OF ACROLEIN IN ALCOHOLIC LIVER DISEASE
Wei-Yang (Jeremy) Chen
November 20, 2014
Alcohol is the most socially accepted addictive drug, and it can cause alcoholic
liver disease (ALD), which is a major cause of morbidity and mortality in the
United States and worldwide. Animal and human studies demonstrate that
chronic alcohol consumption causes a pro-oxidant environment in the liver and
increases hepatic lipid peroxidation and the accumulation of by-products such as
acrolein and 4-hydroxynonenal. Acrolein is the most reactive and toxic aldehyde
generated through lipid peroxidation. Also, acrolein is a major component of
cigarette smoke, and there is increasing evidence that smoking negatively
impacts the incidence, severity, and clinical course of chronic liver disease.
Acrolein is known to form protein adducts, and can trigger endoplasmic reticulum
(ER) stress. Notably, alcohol-induced perturbations in the ER have emerged as
an important etiologic factor in alcoholic liver disease. This study investigated the
role of acrolein as a mediator of hepatic ER stress and injury during alcohol
consumption. Acrolein accumulation, activation of pro-apoptotic stress kinase-
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JNK ( the mitogen activated protein kinase c-jun N-terminal kinase) , ER stress,
and apoptotic cell death was examined in vitro in alcohol-exposed rat hepatic
cells (H4IIEC), and in vivo in a mouse model of alcohol consumption. Exposure
to alcohol led to substantial accumulation of acrolein adducts both in vitro and in
vivo. This was accompanied by phospho-activation of JNK and upregulation of
ER stress transcription factors ATF3 and ATF4, and the pro-apoptotic protein,
GADD153/CHOP. This study demonstrates that acrolein is likely to be a major
culprit in the ER stress and hepatotoxicity associated with alcohol consumption.
Also, the data show that acrolein removal protects against alcohol-induced ER
stress and injury, suggesting that acrolein scavengers may have therapeutic
potential in alleviating the adverse effects of alcohol consumption.
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CHAPTER 1
INTRODUCTION
Alcohol liver disease (ALD)
Alcohol

is

the

most

socially

accepted

addictive

drug,

and

alcohol

abuse/dependence is known to cause chronic organ disorders [1]. Alcohol abuse
is the 3rd leading lifestyle-related cause of death in the United States and there
are approximately 80,000 deaths annually attributed to excessive alcohol use [2,
3]. Binge and underage drinking are common types of excessive alcohol use and
both are also linked to a wide range of health and social problems. Excessive
alcohol use also costs about $185 billion each year in health care and criminal
justice expenses, as well as lost productivity in the United States.
Alcohol quickly distributes into the portal circulation and across biological
membranes to organs throughout the body. Alcohol injuries are observed in
many organs including brain, gastrointestinal tract, immune system, kidney, lung,
heart, pancreas, and particularly, the liver. In the liver, alcohol consumption is
known to cause alcoholic liver disease (ALD) which includes a spectrum of liver
disorders (Figure 1), ranging from fatty liver (steatosis), steatohepatitis, and
fibrosis, to cirrhosis, end stage liver disease and hepatocellular carcinoma (HCC)
[4]. Steatosis is commonly found in approximately 90 percent of individuals who
consume more than 60 g per day of alcohol or about five drinks per day [5].
Steatosis is reversible if the individuals stop or dramatically reduce the amount of
1

alcohol consumption. Histology evidence has shown fat accumulation of both
small (i.e., microvesicular) and large (i.e., macrovesicular) droplets within liver
cells [6]. Some individuals with steatosis progress to more serious liver disease
such as alcoholic hepatitis, which is a steatosis accompanied by inflammation,
neutrophil infiltration, hepatocyte necrosis, and Mallory bodies. Approximately 35
to 40 percent of alcoholic patients may progress from steatosis to fibrosis and
eventually cirrhosis followed by end stage liver disease and hepatocellular
carcinoma (HCC). Currently, there is no FDA approved therapy for any stage of
ALD; hence, the study of mechanisms and mediators that contribute to ALD is
critical to understand the development and progression of ALD and to promote
therapeutic development.

Figure 1: Progression of alcoholic liver disease.
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Alcohol metabolism and oxidative stress
The portal circulation from the intestine passes first through the liver and
ingested alcohol is primarily metabolized in the liver. The process of ethanol
metabolism involves at least three distinct enzymatic pathways.

Most of the

alcohol in the human body is first oxidized in the liver to toxic acetaldehyde,
catalyzed by the cytosolic alcohol dehydrogenase (ADH), an NAD+-requiring
enzyme expressed at high concentrations in hepatocytes. ADH oxidizes ethanol
to acetaldehyde, which enters the mitochondria where it is oxidized to acetate by
one of several aldehyde dehydrogenases (ALDH). Acetaldehyde is then
converted by acetaldehyde dehydrogenase (ALDH) to acetic acid [7]. The
second major pathway for ethanol metabolism is the microsomal ethanol
oxidizing system (MEOS) which involves the cytochrome P450 enzyme 2E1
(CYP2E1) and requires NADPH instead of NAD+ as for ADH. The MEOS
pathway is highly induced in individuals who chronically consume alcohol.
CYP2E1 also plays an important role in alcohol metabolism; alcohol can be
oxidized by CYP2E1 to acetaldehyde, with generation of hydrogen peroxide
which causes oxidative stress in the liver cells. Minor pathways for alcohol
metabolism involve fatty acid ethyl ester (FAEE) synthase, or catalase in
peroxisomes.
Studies have shown that consumption of ethanol disrupts antioxidants function,
which leads to elevated oxidative stress and increased interactions between free
radicals and cellular components including lipids, proteins, and DNA, which alter
cellular structures and functions. Ethanol metabolism is responsible for the
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production of reactive oxygen species (ROS) and a disturbance of cellular
antioxidant capacity. These physiological conditions can be adapted by the
antioxidant systems of the human body. However, when excessive ROS
production goes over the capacity of physiological adaption to eliminate ROS, it
could lead to health problems. The superoxide and hydrogen peroxide are the
most dominant form of ROS and they can cause acetaldehyde accumulation due
to imbalance of redox state. Aldehyde dehydrogenase (ADH) is responsible for
the oxidation of ethanol by increasing the reduced form of nicotinamide adenine
dinucleotide (NADH) which results in decreasing of NAD+/NADH ratio and
triggers the conversion of cytosolic xanthine dehydrogenase to xanthine oxidase
which is the enzyme responsible for the production of superoxide radicals. NADH
is involved in the conversion of ferritin to ferrous (Fe) (II) ions and these ferrous
ions play important roles in free radical reactions which lead to the generation of
hydrogen peroxide, hydroxyl radicals, and increased lipid peroxidation [8, 9].
Alcohol-induced lipid peroxidation
Alcohol metabolism in the liver generates free radicals and these free radicals
can lead to oxidative degradation of cellular polyunsaturated fatty acids (PUFAs),
a process called lipid peroxidation [10]. Linoleic acid (LA) is the most common
PUFA found in all foods in the western diet [11]. The consumption of LA has
dramatically increased from 2% to over 7% in the last decade. Notably, studies
by our group and others have shown that consumption of alcohol along with a
diet rich in PUFA (particularly, LA) gives rise to worse alcohol-induced liver injury,
compared to alcohol and saturated fat diet [12]. Moreover, LA is a precursor of
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arachidonic acid converted to proinflammatory eicosanoids; these are thought to
be involved in several chronic diseases including cancer and cardiovascular
disease [13]. Linoleic acid enriched diet is known to elevate lipid peroxidation [14]
which can generate higher acrolein in the body [15].
Free radicals produced by alcohol metabolism can damage the cells membrane
by stealing electrons from the lipids in cell membranes in the process of free
radical chain reaction. Alcohol-induced lipid peroxidation is well documented in
animal models, as well as in patients with ALD [16]. The products of lipid
peroxidation including malondialdehyde (MDA), 4-hydroxynonenal (4-HNE) and
acrolein are detected in animal blood or tissues and in the humans consuming
alcohol; these highly reactive aldehydes are likely to play a critical role in the
pathology of ALD (Figure 2). Due to their chemical nature, these electrophiles
can react with cellular protein nucleophiles and form aldehyde-modified protein
adducts which generate a pro-oxidative environment in the liver, further
promoting lipid peroxidation. These aldehyde protein adducts can serve as
biomarkers of alcohol-induced oxidative stress in ALD [16].

5

Figure 2: Proposed formation of acrolein from arachidonic acid (PUFA)
[17].

Acrolein, the reactive aldehyde from lipid peroxidation
Acrolein, a highly reactive α,β-unsaturated aldehyde with three carbon and a
double bond structure (Figure 3), is formed endogenously during lipid
peroxidation [18]. Acrolein is also a biotransformation metabolite formed from
certain amino acids, allyl compounds and the anticancer drug cyclophosphamide
[15]. Acrolein has the potential to rapidly deplete cellular glutathione, and
reduces cellular antioxidant capacity [18]. Therefore acrolein may serve as an
important oxidative stress biomarker for lipid peroxidation [19]. Acrolein is the
most toxic and reactive product of lipid peroxidation; indeed, it is over 100 times
6

more reactive than HNE [15]. Due to its highly electrophilic nature, acrolein can
form adducts with cellular nucleophilic groups in lipids, nucleic acids, and
proteins; these acrolein adducts can cause cytotoxicity via irreversible adduction
by disrupting cell signaling and mitochondrial dysfunction of the cells and
produce oxidative stress. Acrolein is associated with several chronic diseases
and elevated concentration of acrolein/acrolein-protein adducts are detected in
the plasma of patients with chronic renal failure, Alzheimer’s disease,
Parkinson’s disease, atherosclerosis, and chronic obstructive lung disease [18].
Notably, acrolein is also an environmental pollutant arising from combustion of
wood, paper, fossil fuels, and plastics. It is a major component of cigarette smoke
and up to 600µg of acrolein is generated per cigarette [20]. This is particularly
relevant for ALD given the high prevalence of individuals that use/abuse both
alcohol and cigarettes. Additionally, acrolein is produced by overheating fats and
oils, and is now considered a significant dietary pollutant occurring in charred
meats and fried foods [18, 20]. Thus, both exogenous and endogenous acrolein
generation may contribute to the development/progression of liver diseases.

Figure 3: Chemical structure of acrolein.
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The pathogenic mechanisms of alcohol liver disease
Some mechanisms postulated to contribute to ALD include inflammation,
mitochondria dysfunction, ER stress, hepatocyte apoptosis and intestinal barrier
dysfunction.
Mitochondria dysfunction
Mitochondria are the energy factory of the cells which produce ATP required to
maintain normal metabolic and repair functions of the cells. Studies have shown
that alcohol significantly decreases the viability of hepatocytes due to inability to
maintain sufficient rate of ATP synthesis. The oxidation of alcohol by ALD and
CYP2E1 and acetaldehyde by ALDH leads to significant increase in the hepatic
NADH/NAD+ ratio and in the production of ROS. The enzyme activities of NADH
dehydrogenase, succinate dehydrogenase and ATP synthase are depressed
when exposed to reactive species, including superoxide, hydrogen peroxide and
peroxynitrite which result in the inactivation of mitochondria proteins and further
decreases the function of mitochondria in the cells [16, 21]. Disruption of
mitochondrial function can trigger signaling cascades involving the release of
pro-apoptotic protein from mitochondria, and activation of initiator and effector
caspases, leading to apoptotic cell death.
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Inflammation
Inflammation is an early indicator of more serious liver disease and several
inflammatory response pathways are linked to alcohol liver disease such as
NFκB, JNK, ROS, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). TNFα is a cytokine which responsible for the programmed cell death and apoptosis of
hepatocytes in alcohol-induced liver injury. TNF-α promotes a series of
inflammation responses in the cells and leads to the production of inflammatory
cytokines such as IL-1β, IL-6, and IL-8 [22]. Persistent cytokine secretion causes
chronic inflammation in the cells which leads to hepatitis, fibrosis, and cirrhosis
[23].
Endoplasmic Reticulum (ER) stress and unfolded protein response (UPR)
The endoplasmic reticulum (ER) is an eukaryotic cell organelle composed of low
concentrations of cholesterol and sphingolipids [24]. The ER plays a crucial role
in cell homeostasis and survival, and is responsible for synthesis, folding,
assembly, and trafficking of proteins, lipid biosynthesis, and regulation of
intracellular

calcium

and

redox

homeostasis

[25].

The

molecular

chaperones/folding proteins in the ER (e.g., Grp78/BiP, Grp94, protein disulfide
isomerase (PDI), calnexin, and calreticulin) ensure that only properly folded
proteins reach their destinations; inappropriately folded proteins are retained in
the ER lumen for refolding or endoplasmic reticulum–associated degradation
(ERAD) [25]. Certain stimuli (such as altered redox status, oxidative stress,
unbalanced calcium, hypoxia, or energy deprivation) can disturb ER function and
lead to the accumulation of unfolded proteins in the ER, thereby triggering ER
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stress and the unfolded protein response (UPR). To restore ER homeostasis, the
UPR adaptive mechanism upregulates the folding capacity of the ER through
induction of chaperones and foldases, and downregulates the biosynthetic load
through inhibition of protein synthesis. UPR adaptive responses can re-establish
homeostasis and reduce ER stress via (i) increased folding capacity through
upregulation of chaperones, and (ii) decreased protein burden through inhibition
of protein synthesis and degradation of misfolded proteins [25].
ER

stress/UPR

signaling

pathways

involves

three

major

ER

resident

transmembrane sensor proteins, inositol requiring protein 1 (IRE1), ds-RNAactivated protein kinase (PKR) like ER kinase (PERK), and activating
transcription factor 6 (ATF6), which are activated from their inhibitory binding with
chaperone GRP78/BiP. The first sensor IRE1, a type I transmembrane protein
with both a serine/threonine kinase domain and an endoribonuclease (RNase)
activities, is activated by transautophosphorylation. IRE1 transcriptionally form
active spliced XBP1 (sXBP1) which activates UPR target genes and ERAD
pathway genes. IRE1 also activates the stress-signaling kinase, JNK, and the
transcription factor NFκB; both of which can lead to proinflammatory cytokine
production. The second sensor PERK, a type I transmembrane protein with a
cytosolic serine/threonine kinase domain, phosphorylates the eukaryotic initiation
factor 2α-subunit (eIF2α), leading to inhibition of translation and reduction of the
protein load during ER stress. Also, p-eIF2α triggers activating transcription
factor 4 (ATF4), which regulates ER chaperone genes, ERAD pathway genes,
amino acid metabolism genes, and the proapoptotic transcription factor C/EBP
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homologous protein (CHOP, GADD153). The third sensor ATF 6, a type II ER
transmembrane protein with a CREB/ATF bZIP transcription factor domain at the
amino terminus, is activated by cleavage in the golgi and can translocate to the
nucleus to activate chaperone gene expression [26, 27]. Additionally, ATF6 also
leads to upregulation of CHOP, and affects SREBP activity and consequently,
lipogenesis.
ER stress induces apoptosis
In order to counter ER stress in the cells, the UPR adaptive signaling pathway is
triggered. However, excessive or prolonged ER stress can overcome the
adaptive pathways, and cause apoptosis and necrotic cell death. The apoptosis
pathway is triggered to protect the liver if the PERK, ATF6, and IRE1 adaptive
pathways fail to mitigate ER stress [28]. Several mechanisms are involved in ER
stress-induced apoptosis such as the transcription factor C/EBP homologous
protein (CHOP), JNK, Bcl-2 family proteins, calcium and redox homeostasis, and
caspase activation [15].
ER stress triggers JNK pathway via phosphorylation of IRE-1 with the adaptor
protein TRAF2 (tumor necrosis factor receptor (TNFR)-associated factor-2) which
phosphorylates and activates JNK [29]. Phosphorylated JNK activates
proapoptotic Bim and inactivates antiapoptotic Bcl-2 proteins, and triggers
release of cytochrome C through the mitochondrial death pathway. Calcium
homeostasis is associated with apoptosis; excess calcium release from the ER
results in calcium accumulation in the mitochondria and results in apoptosis
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effectors release from mitochondria into the cytosol. Bcl-2 has the ability to
reduce overflow of free calcium rest in the ER and prevent cell apoptosis.
The transcription factor CHOP/GADD153 is the best-known proapoptotic
pathway associated with ER stress. CHOP is a bZIP-containing transcription
factor that is a common point of convergence for all three arms of the UPR, with
binding sites for ATF6, ATF4 and XBP1s present within its promoter. CHOP is
primarily considered a pro-apoptotic transcription factor that mediates ER stress
induced cell death through the regulation of Bcl-2 family members. Also, CHOP
transcriptionally induces GADD34 and dephosphorylates p-eIF2α to enable
protein synthesis, concomitantly generating ROS and leading to oxidative stress
and inflammation [15]. The activation of ER stress, and consequent inflammation
and apoptosis may be a significant contributor to many forms of liver injury,
including ALD.
ER stress has been reported to contribute to alcohol-induced liver injury and the
progression of alcohol live disease in both animal and cell models [30-33].
Upregulation of ER stress related genes such as Grp78, Grp94, and CHOP has
been observed in acute and chronic alcohol feeding animal models and in patient
biopsies [34, 35]. Some factors that are thought to contribute to alcohol-induced
ER stress include acetaldehyde, oxidative stress, disrupted calcium homeostasis,
impaired one carbon metabolism, and epigenetic modifications.

12

HYPOTHESIS

We hypothesize that the lipid metabolite acrolein is a major pathogenic
contributor to ALD, based on the knowledge that alcohol metabolism via ADH
and CYP2E1 increases lipid peroxidation leading to the generation/accumulation
of lipid-derived acrolein, which forms protein adducts and triggers ER stress,
ultimately leading to cell death and liver injury.
The study of cellular mechanisms and pathogenic mediators that
contribute to ALD is critical to understand the development/progression of ALD
and to promote therapeutic development. In this study, we investigated the
pathological contribution of acrolein in a murine model of alcohol-induced liver
disease, and we demonstrate that alcohol-induced generation of acrolein in the
liver is a major pathogenic contributor to hepatic ER stress and liver injury in
ALD.
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Figure 4: Alcohol-induced acrolein-mediated ER stress.
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CHAPTER 2
MATERIALS AND METHODS
Animal studies
Male C57BL/6J mice (10 weeks of age) were obtained from Jackson laboratories
(Bar Harbor, ME). They were maintained at 24°C with a 12h:12h light/dark cycle
and had free access to normal chow diet and tap water for 5 days before the start
of the experiment. The mice were fed (ad libitum) a Lieber-DeCarli liquid diet
(Bio-Serv Inc., Frenchtown, NJ) containing 5% ethanol (w/v or 35% of calories) or
maltose dextrin as control for 10 days, followed by a single oral gavage of
ethanol (5g/kg body weight) on day 11. At the end of the experiment, the mice
were anesthetized with Avertin. Plasma and tissue samples were collected for
assays. Part of the liver from the left lobe was harvested and fixed in 10%
neutral-buffered formalin, while the remaining liver tissue was snap frozen in
liquid N2 and stored at −80°C. All mice were treated according to the protocols
reviewed and approved by the Institutional Animal Care and Use Committee of
the University of Louisville.
Reagents
General chemicals, N-acetyl cysteine (NAC), acrolein, and β-actin antibody were
purchased from Sigma Aldrich (St. Louis, MO). All other antibodies were
purchased from Cell Signaling (Beverly, MA). Cell culture supplies were
obtained from Invitrogen (Carlsbad, CA).
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Cell culture
H4IIEC, a rat hepatoma cell line obtained from American Type Culture Collection
(Rockville, MD) was used according to company instructions. All treatments
were performed on sub-confluent monolayers of cells. Cells were plated at the
following densities: (i) 20,000 cells per well for 96-well plates; (ii) 0.25x106 cells
per well for 24-well plates; (iii) 0.5x106 cells per well for 6-well plates; (iv) 2.5x106
cells per 100mm plates. Cells were cultured in the DMEM media (10% horse
serum, 5% .Cells were counted using a hemocytometer.
Isolation of RNA and RT-PCR
The messenger RNA (mRNA) levels of ER stress genes were analyzed by real
time polymerase chain reaction (RT-PCR). 300ng of total RNA, isolated using
Trizol (Invitrogen, Carlsbad, CA), was used in reverse transcription reactions as
described by the manufacturer. The resulting complementary DNA was then
subjected to PCR using specific primer pairs (Table 1), with 18s and TATAbinding protein as internal controls. SYBR Green I dye was used for Real Time
PCR in an ABI prism 7500 sequence detection system.
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Mouse
mATF3_F1
mATF3_R1
mATF4_F1
mATF4_R1
mDDIT3_GADD_CHOP_F1
mDDIT3_GADD_CHOP_R1
mGRP78_F1
mGRP78_R1
mGRP94_F1
mGRP94_R1
Rat
rATF3_F1
rATF3_R1
rATF4_F1
rATF4_R1
rDDIT3_GADD_CHOP_F1
rDDIT3_GADD_CHOP_R1
rGRP78_F1
rGRP78_R1
rGRP94_F1
rGRP94_R1
Human/Rat/Mouse
18Sreg3F
18Sreg3R
hrm_Tbp_F
hrm_Tbp_R

GCGCTGGAGTCAGTTACCGTCA
TTCTTCAGGGGCCGCCTCAGAC
AAGCCATGGCGCTCTTCACGA
AGTCCCCCGCCAACACTTCG
CCGGAACCTGAGGAGAGAGTGTT
AGCTGCCATGACTGCACGTGG
ACCACCTATTCCTGCGTCGGTGT
AGGCCACATACGACGGCGTG
AAAGGACTTGCGACTCGCCGG
TCTGACGAACCCGAAGGTCAGC
GGGCCACCTCAGACTTGGTGACT
CATCGGATGTCCTCTGCGCTGG
GACAAGGCGGGCTCCTCAGAA
AAAGGCATCCTCCTTGCCGGTGT
TGTTGAAGATGAGCGGGTGGCAG
TGGACCGGTTTCTCTCTCCTCAGGT
GGACCACCTATTCCTGCGTCGGT
TGGCCGCATCGCCAATCAGA
CGTCCTGCTGACCTTCGGGTTT
CCAGGTCCTCTTCTACCGTGCCA
CTCAACACGGGAAACCTCAC
CGCTCCACCAACTAAGAACG
CCTAAAGACCATTGCACTTCGT
GCTCCTGTGCACACCATTTT

Table 1: Primers for quantitative Real Time-PCR.
MTT assay
Cell

viability

was

assessed

by

the

3-(4,5-dimethythiazol-2-yl)-2,5-

diphenyltetrazolium bromide (MTT) assay. After treatments, cells were washed
twice with PBS; then cell culture medium was replaced with medium containing 1
mg/ml MTT. After 1h, cells were lysed with100ul lysis buffer containing 20% SDS
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and 50% N,N-dimethyformamide (DMF), and incubated at 37°C overnight. The
OD values were read at 570 nm.
Western blot analysis
Western Blot Analysis: Cells were lysed in lysis buffer (50 mM Tris•HCl, pH 7.4,
150 mM NaCl, 2 mM EDTA, 4 mM Na3VO4, 40 mM NaF, 1% Triton X-100, 1 mM
PMSF, 1% protease inhibitor cocktail) and centrifuged at 14,000 g for 10 min.
The supernatants were collected and 26μg of equivalent protein in total cell
lysates was resolved by SDS-polyacrylamide gel electrophoresis and transferred
onto a polyvinylidene difluoride membrane ((Bio-Rad, Hercules, CA). Membranes
were blocked for 1 h in blocking buffer (5% nonfat dry milk in 0.1%TBST (10 mM
Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Tween 20)) and incubated overnight
at 4°C with the primary antibodies diluted in blocking buffer. After washing with
0.1%TBST, the membranes were incubated with appropriate secondary
antibodies for 1 h at room temperature. Proteins were visualized using an
enhanced chemiluminescence system (ECL, GE Healthcare, Piscataway, NJ)
and quantified by densitometry analysis using UNSCANIT (Silk Scientific, Inc,
Orem, UT). The density ratio of each band compared to its corresponding βactin band was determined. The density ratio was normalized to the untreated
value which was set to 1.
Liver histology:
Liver sections were fixed in 10% buffered formalin for 24 hours and embedded in
paraffin. Tissue sections were deparaffinized, stained with hematoxylin–eosin
(H&E), and examined by light microscopy (×200 final magnification).
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ALT & AST assay
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity
was measured as a marker of liver injury using commercially available reagents
from Thermo Fisher Scientific Inc. (Middletown, VA).
Oil Red O staining
Frozen liver sections were washed in phosphate buffered saline twice for 5
minutes. Oil-Red-O and 85% propylene glycol were added with agitation for 15
minutes, followed by washing in tap water.
Detection of apoptosis and acrolein adducts
TUNEL staining for apoptosis was performed using ApopTag® Peroxidase In
Situ Apoptosis Detection Kit (EMD Millipore Corporation, Billerica, MA). Acrolein
adducts were detected using an antibody specific for FDP-Lysine acrolein
adducts obtained from Cell Sciences. (Canton, MA). Quantitation was done and
calculated by MetaMorph microscope. Ten pictures from each liver were used for
analyses.
Statistical analysis
Statistical analysis was performed using GraphPad Prism version 5.01 for
Windows (GraphPad Software, Inc., La Jolla, CA). One-way analysis of variance
(ANOVA) followed by Tukey’s post hoc test was used to evaluate significant
differences between the compared groups. A p-value of <0.05 was considered
statistically significant. Data were expressed as mean ± SEM.
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CHAPTER 3
RESULTS
In this study, we have examined the contribution of the lipid-derived aldehyde,
acrolein, to alcohol-induced liver injury in a “chronic+binge” murine model of ALD.
This model reflects a common drinking pattern in humans, particularly in patients
with ALD who are often chronic and binge drinkers. Moreover, the model has the
advantage of shorter duration with increased liver inflammation and injury as
compared to other alcohol feeding models [36, 37]. Figure 5 is a schematic
representation of the mouse model of alcohol-induced liver injury in early ALD.
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Figure 5: Schematic of murine model of alcohol consumption and ALD.
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Alcohol consumption results in the accumulation of acrolein adducts in the
liver
Alcohol consumption is known to upregulate CYP2E1 and increase oxidative
stress and LPO, and hence is expected to generate higher levels of the lipidderived aldehyde, acrolein. Free acrolein is extremely labile and reactive, and
difficult to quantify; moreover, it is known to react with amino acid side chains,
particularly lysine and cysteine, and can form adducts with cellular proteins.
Accordingly, we examined (i) CYP2E1 gene expression and protein levels, and (ii)
the levels of acrolein-protein adducts in the livers of control versus alcohol-fed
mice. Alcohol feeding led to a robust increase in CYP2E1 protein levels (Figure
6A), but interestingly CYP2E1 mRNA was down-regulated in the alcohol-fed mice.
Consistent with CYP2E1protein upregulation, a corresponding increase was
observed in the levels of acrolein-protein adducts in the liver (Figure 6B). Some
liver sections in the alcohol group had slightly higher accumulation of alcoholinduced acrolein adducts around the central veins, however, there was no zonespecific accumulation, and there was no particular increase in acrolein adducts at
the sinusoids. In the majority of liver sections, elevated acrolein staining was
seen in both cytoplasm and nuclei of hepatocytes. The acrolein adduct
accumulation was quantified and there was a statistically significant difference in
the adduct levels between control and alcohol-fed livers. Consistent with
increased acrolein adducts, alcohol exposed mice also developed microvesicular
and macrovesicular liver steatosis as compared to controls, as evaluated by
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histological examination (Figure 6C) and confirmed by Oil-Red-O staining (Figure
6D).
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Figure 6A. Alcohol consumption decreases mRNA and increases CYP2E1
protein levels in mouse livers.
Top: CYP2E1 mRNA by real time-PCR. Data are presented as the mean ± SD.
Statistical analysis was done by student’s t-test. *p,0.05, ***p<0.001compared to
control (n=5). Bottom: CYP2E1 protein by Western blot analysis of total lysates.
Blots were reprobed with antibody to β-actin to ensure equivalent loading.
Densitometry analysis was performed using Imagelab software. Density ratio was
calculated using β-actin as control. Numbers represent the mean of density ratio
for each group of Control (C) and alcohol-fed (E) mice.
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Figure 6B. Alcohol consumption leads to accumulation of acrolein adducts
in mouse livers.
Top: Immunostaining for Acrolein FDP-lysine adducts in liver of control (C) and
alcohol-fed (E) mice from 10+1 chronic alcohol binge model. 5μM liver sections
were stained with antibodies for acrolein FDP-lysine adducts. Brown color
indicates presence of acrolein adducts (denoted by arrows).
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Bottom: Quantification of acrolein adducts by percentage positive microscope
fields was calculated by MetaMorph microscopy in control (C) and alcohol-fed (E)
mice. Data are presented as the mean ± SD. Statistical analysis was done by
student’s t-test. ***p<0.001 compared to untreated control (C) (n=10).
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Figure 6C. Alcohol consumption results in hepatic steatosis in mouse
livers.
Liver were stained with Hematoxylin and Eosin staining (H&E, ×200 final
magnification). Alcohol exposure resulted in microvesicular and macrovesicular
fat accumulation. Liver sections from mice fed control diet (C) or alcohol (E).
Arrows indicate the fat droplets.
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Figure 6D. Alcohol consumption results in hepatic steatosis in mouse
livers.
Liver sections from mice fed control diet (C) or alcohol (E) were stained with OilRed-O (×20 final magnification). Alcohol exposure resulted in microvesicular and
macrovesicular fat accumulation (red color).
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Alcohol-induced hepatic accumulation of acrolein adducted proteins
causes ER stress
The alcohol-induced accumulation of acrolein adducted proteins in the liver is a
likely burden on the ER protein folding machinery, which if overwhelmed can
result in the induction of ER stress and activation of UPR. To evaluate the
consequence of alcohol-induced acrolein adduct accumulation, we therefore
examined hepatic ER stress following alcohol feeding. Indeed, alcohol feeding
and resultant accumulation of acrolein adducts led to ER stress and extensive
upregulation of the prototypical ER stress markers, activating transcription factors
ATF3 and ATF4, at the mRNA (Figure 7A). In agreement with gene expression,
western blot analysis also demonstrated increased protein levels in the livers of
alcohol-fed animals (Figure 7B). The increase in ATF3 and ATF4 could be
attributed to phospho-activation of the upstream signaling proteins, PKR-like
endoplasmic reticulum kinase (PERK) and eukaryotic translation initiation factor
2A, (eIF2α) (Figure 7B). The effect of alcohol consumption was also examined on
gene expression of ER chaperone proteins GRP-78 and GRP94, which are
upregulated as part of the adaptation responses to ER stress. Alcohol feeding
increased the mRNAs of both GRP78 and GRP94 to a small but statistically
significant extent (Figure 7A); however, at the protein level, only GRP78 was
elevated (Figure 7B).
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Figure 7A. ER stress gene expression is up-regulated in mouse livers.
mRNA expression was examined by real-time PCR using primers specific for
ATF3, ATF4, GADD/CHOP, GRP78, and GRP94 genes. Data are presented as
the mean ± SD (n=6). Statistical analysis was performed using GraphPad Prism
Software using one-way ANOVA followed by Bonferroni posttest. *P<0.05,
**P<0.01.
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Figure 7B. Alcohol consumption induces ER stress in mouse livers.
Western blot analysis of ATF3, ATF4, GADD/CHOP, GRP78, GRP94, and ATF6
was performed using total cell lysates. Blots were reprobed with antibody to βactin to ensure equivalent loading. Statistical analysis was performed using
GraphPad Prism Software using one-way ANOVA followed by Bonferroni
posttest. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin as control. Numbers represent the mean of
density ratios for each group of mice pair-fed control or ethanol diet.
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Alcohol-induced hepatic acrolein build-up and consequent ER stress lead
to apoptotic signaling, hepatocyte death and liver injury
ER stress-induced apoptosis is thought to occur via various apoptotic pathways.
The first is activation by phosphorylation of the stress kinase JNK (cJUN NH2terminal kinase), which is primarily involved in proinflammatory signaling and
gene expression, but is also linked to hepatocyte apoptosis. Another arm of ER
stress-associated apoptosis is postulated to involve activation of caspase-12
(caspase-4 in humans), a phylogenetic family member of the inflammatory
caspases which is proteolytically activated during ER stress-induced cell death
[38], rather than other apoptotic pathways. ER stress increases cytosolic calcium
and activates m-calpain, which cleaves Bcl-XL and proteolytically activates
caspase12; active caspase12 then activates caspase-9 and caspase-3 [39],
resulting in apoptosis. The third and possibly the most important pathway of ERstress induced apoptosis is upregulation of C/EBP homologous protein (CHOP,
GADD153), the pro-apoptotic protein primarily responsible for ER stress-induced
cell death. Accordingly, we examined these apoptotic signals following alcohol
feeding in mice.
In hepatocytes, JNK1 (46kDa) and JNK2 (54kDa) are expressed and sustained
JNK activation has been implicated in several forms of liver injury. In particular, it
is thought that JNK1 may be responsible for inducing cell death, and JNK2 may
primarily promote proliferation. In our model system, alcohol caused a significant
phospho-activation of JNK1 which was undetectable in control mice, while
phospho-JNK2 was detected in both control and alcohol fed mice at the same
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level (Figure 8). Also, alcohol feeding led to proteolytic activation of caspase12,
with a decrease in pro-caspase12 (apparent ~55kDa) and a concurrent increase
in the cleaved form (38kDa) in mice fed alcohol compared to controls (Figure 8).
Notably, alcohol consumption also led to the induction of C/EBP homologous
protein (CHOP, GADD153). CHOP is a pro-apoptotic basic-leucine zipper (bZIP)containing transcription factor which is a point of convergence for all three arms
of UPR; CHOP has binding sites within its promoter for ATF6, ATF4 and XBP1.
CHOP mediated upregulation of Bim and downregulation of Bcl-2 has been
reported as the primary mechanism by which CHOP favors pro-apoptotic Bcl-2
proteins and mediates ER stress induced cell death. CHOP mRNA was
increased approximately 5-fold (Figure 7A) and CHOP protein was dramatically
upregulated in the alcohol-fed group compared to control (Figure 8).
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Figure 8. Hepatic activation of JNK, induction of ER stress proteins, and ER
stress induced apoptotic proteins in mouse livers.
Western blot analysis of p-JNK, p-eIF2α, GADD/CHOP, and Caspase 12 was
performed using total cell lysates. Blots were reprobed with antibody to β-actin to
ensure equivalent loading. Statistical analysis was performed using GraphPad
Prism Software using one-way ANOVA followed by Bonferroni posttest. **P<0.01.
Densitometry analysis was performed using Imagelab software. Density ratio was
calculated using β-actin as control. Numbers represent the mean of density ratio
for each group of mice pair-fed control or ethanol diet.

34

The observed alcohol-induced activation of apoptotic signals culminates in
apoptotic cell death of hepatocyte in the livers of alcohol-fed mice, as seen by an
increase in TUNEL positive staining in the livers of alcohol-fed mice compared to
control (Figure 9A, apoptotic cells denoted by arrows). Consistent with elevated
apoptosis in the liver, alcohol-fed mice exhibited higher liver injury as compared
to control; liver injury was defined by elevated serum ALT (53.89 ± 9.93 vs.
7.21 ± 1.05 U/l, p < 0.05), and AST (66.35 ± 25.87 vs. 11.06± 2.18 U/l, p < 0.05)
activities (Figure 9B). Thus, alcohol-induced accumulation of acrolein and
consequent ER stress resulted in hepatocyte apoptosis leading to liver injury in
mice fed alcohol.
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Figure 9A. Alcohol consumption results in hepatic apoptosis by terminal
transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL)
staining assay.
TUNEL staining of liver sections from Control (C) and alcohol (E) fed mice.
Arrows indicate TUNEL-positive cells.

Figure 9B. Alcohol consumption leads to liver injury (serum ALT and AST).
Control (C) and alcohol (E). AST and ALT serum levels were measured by
commercial kits as described in methods. Data are presented as the mean ± SD.
Statistical analysis was done by t-test. **p<0.01 compared to Control and
***p<0.001 compared to Control (n=6).
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Acrolein mimics the in vivo effects of alcohol in cultured hepatic cells.
Alcohol consumption and metabolism in the liver is capable of giving rise to many
toxic metabolites including acetaldehyde, HNE and acrolein. To isolate and
determine the sole contribution of acrolein in alcohol-induced hepatic injury, we
used cultured rat hepatic H4IIEC cells to examine the direct in vitro effects of
acrolein exposure in comparison to alcohol exposure. These cells are well
characterized model system for hepatocytes and importantly, are known to
metabolize alcohol. We first assessed whether in vitro exposure to alcohol
resulted in the accumulation of acrolein adducts, similar to adducts seen in
alcohol-fed mouse livers. H4IIEC cells were treated for 24h with relevant
concentrations of alcohol (200mM) and acrolein (20µM). Considerable acrolein
adduct accumulation was seen within 6h of alcohol exposure and acrolein adduct
levels continued to be elevated at 24h compared to untreated cells (Figure 10A).
Interestingly, the in vitro acrolein adduct accumulation appeared to be greater in
the cell cytoplasm, rather than the nucleus; whereas in vivo, acrolein adducts
were equally distributed throughout the cells.
To further characterize the acrolein-protein adducts, we subjected total protein
extracts from treated cells to Western blot analysis (Figure 10B). Compared to
untreated cells, we observed a significant increase in the overall levels of
acrolein-FDP lysine adducts in the cells treated for 24h with acrolein or alcohol.
In particular, three proteins with an estimated molecular mass of 46kDa, 56kDa
and 64kDa were considerably elevated in both alcohol and acrolein exposed
cells. The identity of these proteins is currently unclear and under investigation.
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Figure 10A. Acrolein adduct accumulation in H4IIEC cells (Immunostaining
with acrolein FDP-lysine antibody).
Control (C); 200mM Alcohol (E); 20μM Acrolein (A) for 24 hours. Brown color
indicates presence of acrolein adducts.

Figure 10B. Acrolein adduct accumulation in H4IIEC cells (Western Blot).
H4IIEC cells were treated with varying concentrations of alcohol (50mM, 100mM,
and 200mM, denoted by E50, E100, and E200) and acrolein (20μM and 30μM,
denoted by A20 and A30) 24 hours. Western blot analysis was performed using
total lysates. Blots were reprobed with antibody to β-actin to ensure equivalent
loading. Densitometry analysis was performed using Imagelab software. Density
ratio was calculated using β-actin as control. Numbers represent the means of
density ratio for each treatment.
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Next, we determined the effects of alcohol and elevated acrolein on induction of
ER stress and consequent apoptotic cell death in hepatocytes. We exposed
H4IIEC cells to different concentrations of either ethanol (50mM, 100mM or
200mM) or acrolein (20µM or 30µM). Similar to in vivo alcohol exposure, alcohol
triggered ER stress and caused increased gene expression of ATF3, ATF4
mRNA (Figure 11A) and protein (Figure 11B). A parallel result was seen with
direct treatment of cells with acrolein (Figure 11A and 11B). As seen with in vivo
alcohol exposure, the adaptive responses to ER stress, namely, upregulation of
GRP78 and GRP94, were not robust (Figure 11A and 11B). Notably,
proapoptotic CHOP was significantly upregulated at both mRNA and protein
levels (Figure 11A and 11B). The up-regulation of proapoptotic signal and CHOP
expression resulted in apoptotic cell death and decreased cell survival by MTT
assay (Figure 11C).Thus, our data demonstrate that acrolein mimics the effects
of alcohol in cultured hepatic cells, suggesting that the adverse effects of alcohol
may indeed be attributed to elevated acrolein in the liver, occurring as a result of
alcohol consumption.
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Figure 11A. Exposure of H4IIEC cells to alcohol or acrolein causes
upregulation of ER stress genes by Real time qPCR.
C=Control; E=alcohol (mM); A=Acrolein (µM). Data are presented as the mean ±
SD. Statistical analysis was performed using GraphPad Prism Software using
one-way ANOVA followed by Bonferroni posttest. *p<0.05, **p<0.01, n=3.
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Figure 11B. ER stress gene expression ATF3, ATF4, GADD/CHOP, GRP78,
and GRP94 by alcohol (E) or acrolein (A).
H4IIEC cells were treated with varying concentrations of ethanol (50mM, 100mM,
and 200mM) and acrolein (20μM and 30μM) 24 hours. Western blot analysis was
performed using total cell lysates. Blots were probed with ATF3, ATF4,
GADD/CHOP, GRP78, and GRP94 antibody, then stripped and reprobed with
antibody to β-actin to ensure equivalent loading. Densitometry analysis was
performed using Imagelab software. Density ratio was calculated using β-actin as
control. Numbers represent density ratio for each treatment.
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Figure 11(C). Cell viability of hepatocytes from alcohol (E) or acrolein (A)
toxicity.
Cell viability was measured by MTT assay as described in methods. Alcohol
200mM (E200) and acrolein 20μM (A20). Data are presented as the mean ± SD.
Statistical analysis was performed using GraphPad Prism Software using oneway ANOVA followed by Bonferroni posttest. *p<0.05 compared to Control (n=3).
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Acrolein scavengers were effective in attenuating the adverse effects of
both acrolein and alcohol exposure in vitro
In order to confirm the contribution and establish the pathogenic role of acrolein
in alcohol-induced ER stress and liver injury, we used known acrolein
scavengers (N-acetyl cysteine, carnosine and hydralazine) to try to mitigate the
injurious effects of acrolein build-up in hepatocytes resulting from alcohol and
acrolein exposure. Acrolein is known to rapidly deplete cellular GSH and cause
oxidative stress in hepatocytes [1]. Hence, we tested the N-acetylcysteine (NAC),
a glutathione precursor and antioxidant that was shown to build up intracellular
GSH and protect against acrolein-induced apoptosis [1, 40]. Carnosine (betaalanyl histidine) is an endogenous protein building block that is known to
scavenge aldehydes, such as acrolein, and to inhibit harmful oxidation and
glycation reactions [41]. Carnosine is thought to help against aging, autism,
cataracts, brain and kidney disorders, and diabetic complications. H4IIEC cells
were pretreated with NAC or carnosine for 45m prior to exposure to alcohol or
acrolein, and the effects were studied on cell viability. Cell death was monitored
by the MTT assay. The data show that both NAC and carnosine partially
attenuated the cytotoxic effects of alcohol and acrolein (Figure 12).
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Figure 12. Acrolein scavengers protect hepatocytes from alcohol (E) or
acrolein (A) toxicity.
Cell viability was measured by MTT assay as described in methods. Control (C);
20μM Acrolein (A); 200mM Alcohol (E). Data are presented as the mean ± SD
(n=3). Statistical analysis was performed using GraphPad Prism Software using
one-way ANOVA followed by Bonferroni posttest. *p<0.05.
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Another acrolein scavenger, hydralazine, which is a vasodilator and
hypertension drug, is highly selective and effective in preventing acroleinmediated oxidative stress and cell death in PC12 cells, and tissue injury in spinal
cord injury models [42]. Notably, the cytoprotective effects of hydralazine are
shown to occur not merely by acrolein scavenging but also by effective trapping
of acrolein-protein adducts [43]. We tested the protective effects of hydralazine
against acrolein cytotoxicity in vitro (Figure 13A) and against alcohol-induced
liver injury in vivo in the NIAAA mouse model (Figure 13B).
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A.

B.

Figure 13. Acrolein scavengers protect from acrolein cytotoxicity in vitro
(A), and alcohol-induced liver injury in vivo (B).
(A) Cell viability was measured by MTT assay as described in methods. Control
(C); 30μM Acrolein (A30). 50μM Hydralazine (HYD). 100μM Carnosine (CAR)
(B) Serum ALT was measured by commercial activity assay kit. Control (C),
Alcohol (E), (5mg/kg) body weight Hydralazine (HYD). Statistical analysis was
done by (A) ANOVA. *p<0.05 compared to Control. (B) ANOVA. ***p<0.001
compared to Control (n=5).
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CHAPTER 4
DISCUSSION
In this study, we examined using in vitro (rat hepatic H4IIEC cells) and in vivo
(C57Bl/6 mice - chronic+binge (NIAAA) alcohol feeding) models how acrolein
plays a key role on hepatic effects in alcoholic liver disease. We investigated the
effects of alcohol or acrolein on hepatic ER stress and cell death, and studied
how acrolein contributed to liver injury in the alcoholic liver disease. Finally,
acrolein scavengers were tested as potential therapeutic agents in ALD by
examining their protective effects in the prevention of alcohol-induced ER stress
and injury cell death.
Oxidative stress is a salient feature of ALD, and oxidative stress has been
demonstrated in the absence of ER stress in alcohol fed mice [44]. In the present
study our experimental results demonstrate elevated protein level of CYP2E1 in
the livers of alcohol-fed mice following alcohol exposure. Also, the accumulation
of acrolein adducts were detected in alcohol fed mice liver indicating that alcohol
consumption results in considerable generation of lipid peroxidation product,
acrolein, leading to the buildup of acrolein adducts. These results were also
supported by in vitro acrolein adducts staining in rat hepatocyte H4IIEC treated
with alcohol or acrolein which indicated the formation of acrolein adducts from
alcohol treatment in vitro. Compared to untreated cells, we observed a significant
increase in the overall levels of acrolein-FDP lysine adducts in the cells treated
for 24h with acrolein or alcohol. Increased acrolein adducts were detected in vivo
and in vitro, both in the cytoplasm as well as the nuclei. The accumulation of
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cytoplasmic adducts is likely to directly trigger ER stress and alter calcium
homeostasis, and may also lead to the mitochondrial permeability changes that
are associated with ALD. The nuclear association of acrolein adducted proteins
is especially interesting and may indicate changes in transcription factors or
chromatin-modifying proteins such as histone deacetylases and DNA/histone
methylases, which are likely to have significant effects on gene expression.
Interestingly, in vitro exposure to either alcohol or acrolein for 24h resulted
predominantly in cytoplasmic acrolein adducts; the significance of this finding is
not clear and it is possible that longer exposures may be needed for nuclear
acrolein buildup. By western blot analysis, we observed an increase in several
proteins; however, three proteins with an estimated molecular mass of 46kDa,
56kDa and 64kDa were considerably elevated. The identity of these proteins is
currently under investigation.
Our results demonstrate hepatic ER stress and injury in the NIAAA model of
chronic + binge alcohol consumption. Notably, all three ER stress/UPR pathways
were stimulated with phosphorylation of PERK, eIF2α, and JNK, proteolytic
activation of ATF6α, and upregulation of ATF3 and ATF4 mRNA and proteins.
The mechanisms by which acrolein affects ER stress proteins may be direct via
adduction of ER stress molecules, or indirect via adduction and alteration of
function of other proteins that regulate the transcription, translation, stability or
localization of the ER response proteins. A direct adduction of the ER chaperone
GRP78 by the lipid aldehyde HNE was shown by Galligan et al, 2014 [45];
notably, although HNE adduction led to a decrease in ATP binding, no change
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was seen in the chaperone activity of GRP78 [45]. Notably, among the ER
chaperone proteins, GRP78 mRNA and protein were upregulated but GRP94
was only minimally increased (~1.3 fold) at the mRNA level in this in vivo model
of ALD. Thus, the adaptive responses were not robust and appeared inadequate.
This is in keeping with the in vitro alcohol and acrolein exposure in H4IIEC cells
showing modest increase in mRNA but no increases in protein level of GRP78 or
GRP94; these data are also similar to our published work in HepG2 cells that do
not express alcohol dehydrogenase or CYP2E1 and are unable to metabolize
alcohol [1]. The alcohol-induced acrolein accumulation and ER stress were
associated with significant hepatic steatosis, hepatocyte apoptosis and liver
injury with a highly significant increase in AST and AST in the alcohol fed mice.
Thus, these data suggest that alcohol consumption leads to acrolein adducts
accumulation in the liver, with ER stress and apoptosis, which correlate with liver
injury.
Overall, our results suggest that the effects of alcohol on hepatic ER stress and
hepatocyte cell death and liver injury are mediated, at least in part, by acrolein,
which is substantially generated with alcohol consumption/metabolism. This
result is further supported by the in vitro data in H4IIEC cells treated with acrolein
alone showing that acrolein is able to fully mimic the in vivo effects of alcohol.
Finally, our data demonstrating that acrolein removal by acrolein scavengers
protected cells against alcohol induced apoptosis confirmed that acrolein is
indeed a major mediator of alcohol-induced injury. The mechanisms underlying
the alcohol-induced acrolein-mediated ER stress and apoptotic injury requires
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further investigation. Additionally, our data indicate that acrolein clearance may
be an effective means of curtailing alcohol-induced acrolein-mediated hepatic
injury, and may be effective clinically protective agents for alcoholic liver disease.
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SIGNIFICANCE AND CLINICAL RELEVANCE
Alcohol consumption causes alcoholic liver disease (ALD) which remains a major
cause of morbidity and mortality worldwide. Currently, there is no FDA approved
therapy for ALD. Of the people who drink heavily, only a subset develop clinically
important ALD and dietary and environmental factors may be critical
determinants. Dietary polyunsaturated fatty acids (PUFAs), particularly linoleic
acid, promote alcohol-induced liver damage; linoleic acid consumption has
dramatically increased and is now a major fat source in the Western diet. Alcohol
consumption increases lipid peroxidation of PUFAs leading to the generation and
accumulation of lipid-derived oxidized metabolites, such as acrolein.
In this study, we investigated the pathological contribution of acrolein in alcoholinduced liver disease using in vitro (rat hepatic H4IIEC cells) and in vivo (C57Bl/6
mice - chronic+binge (NIAAA) alcohol feeding) model systems. Our data
demonstrate that alcohol-induced generation of acrolein in the liver is a major
pathogenic contributor to hepatic ER stress and liver injury in ALD. Additionally,
our data indicate that acrolein clearance may be an effective means of curtailing
alcohol-induced acrolein-mediated hepatic injury, and acrolein scavengers may
be effective clinical therapeutic agents for Alcoholic Liver Disease.
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